batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. PTK7 seems key for Kelun 21 August 2024 Kineta is down, but not yet out 20 August 2024 Tissue factor tempts Adcendo 20 August 2024 J&J gets its first broad Rybrevant nod 20 August 2024 Dosing limit solves BioNTech's clinical hold 19 August 2024 Monjuvi scores a qualified indolent lymphoma success 16 August 2024 Lynparza’s endometrial cancer first comes in the EU 15 August 2024 Front-line setting next for axatilimab 15 August 2024 Load More